IRLAB Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
21 May 24 | BuySEK 62,200 | Carola Lemne | Individual | 4,000 | SEK 15.55 | |
21 May 24 | BuySEK 122,400 | Catharina Wallich | Individual | 8,000 | SEK 15.30 | |
14 May 24 | BuySEK 31,000 | Gunnar Olsson | Individual | 2,000 | SEK 15.50 | |
13 May 24 | BuySEK 68,037 | Viktor Siewertz | Individual | 5,000 | SEK 13.61 | |
10 May 24 | BuySEK 259,680 | Daniel Johnsson | Individual | 20,000 | SEK 12.98 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 7,040,054 | 13.6% |
Individual Insiders | 11,568,538 | 22.3% |
Institutions | 12,998,262 | 25.1% |
General Public | 20,261,552 | 39.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
4,893,580 | SEK 75.9m | 0% | 0.06% | |||
4,520,000 | SEK 70.1m | 0% | no data | |||
3,826,638 | SEK 59.3m | 0% | 100.0% | |||
3,665,626 | SEK 56.8m | 0% | no data | |||
3,495,420 | SEK 54.2m | 0% | 0.02% | |||
1,517,106 | SEK 23.5m | 0% | no data | |||
1,208,250 | SEK 18.7m | 0% | no data | |||
800,000 | SEK 12.4m | 0% | no data | |||
757,535 | SEK 11.7m | 0% | no data | |||
745,146 | SEK 11.5m | 0% | no data | |||
695,000 | SEK 10.8m | 0% | no data | |||
631,367 | SEK 9.8m | 0% | no data | |||
631,367 | SEK 9.8m | 0% | no data | |||
612,954 | SEK 9.5m | 0% | no data | |||
530,636 | SEK 8.2m | 0% | no data | |||
522,063 | SEK 8.1m | 0% | no data | |||
450,000 | SEK 7.0m | 0% | no data | |||
385,542 | SEK 6.0m | 0% | no data | |||
365,210 | SEK 5.7m | 0% | no data | |||
294,684 | SEK 4.6m | 0% | no data | |||
261,925 | SEK 4.1m | 0% | no data | |||
251,161 | SEK 3.9m | 0% | no data | |||
238,965 | SEK 3.7m | 0% | no data | |||
131,617 | SEK 2.0m | 0% | 0.02% | |||
60,000 | SEK 930.0k | 0% | no data |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/20 14:59 |
End of Day Share Price | 2025/01/17 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
IRLAB Therapeutics AB (publ) is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Gonzalo Artiach Castanon | ABG Sundal Collier Sponsored |
null null | ABG Sundal Collier Sponsored |
Soo Romanoff | Edison Investment Research |